In Re: National Prescription Opiate Litigation

Track this case

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. November 03, 2020

    McKesson, 2 Other Distributors Ink $21B Opioid Settlement

    Three opioid distributors have agreed to pay up to $21 billion to settle sprawling litigation over their alleged role in fueling the opioid crisis that has destroyed countless Americans' lives, an attorney involved in the negotiations told Law360 on Tuesday.

  2. November 02, 2020

    W.Va. Gov'ts Rip Bid To Block Opioid Victims' Testimony

    Two West Virginia governments set to bring one of the first trials in nationwide opioid-crisis litigation are criticizing opioid distributors' bid to exclude testimony by people who have suffered from the crisis.

  3. October 20, 2020

    Opioid Settlements Stymied By Atty Fee Demands, AGs Say

    Massive fee demands from plaintiffs attorneys in multidistrict opioid litigation are the main reason settlements haven't been finalized with major drug companies in a broader wave of opioid cases, two state attorneys general said Tuesday, a provocative claim that drew a fast and fiery backlash.

  4. October 14, 2020

    Allergan, Teva Sanctioned For Flouting Opioid MDL Discovery

    An Ohio federal judge sanctioned Allergan and Teva Pharmaceuticals after concluding Wednesday that they didn't search diligently for a damning internal audit of efforts to spot suspicious opioid orders and likely would have done so if the audit helped their legal defense in multidistrict litigation.

  5. October 13, 2020

    J&J Strikes $5B Deal Pushing 3,000 Opioid Suits Toward End

    Johnson & Johnson on Tuesday disclosed that it's offering up to $5 billion to end a nationwide torrent of litigation accusing it of contributing significantly to America's opioid addiction crisis, a 25% increase on an earlier settlement proposal.

  6. October 09, 2020

    Drug Cos. Fight Class Cert. For 'Opioid Babies' In MDL

    Drugmakers and retailers facing multidistrict litigation over their alleged role in the opioid epidemic urged a federal judge Friday not to certify a class of legal guardians of babies born to mothers who took opioids during pregnancy, saying their personal injury claims can't be resolved collectively.

  7. October 09, 2020

    Opioid MDL Bellwether Trial Delayed Amid COVID-19 Fears

    Amid coronavirus concerns, a West Virginia federal judge on Friday postponed an eagerly awaited bellwether trial in multidistrict opioid litigation shortly before its scheduled start, adding to a series of recent setbacks for local governments that blame drug companies for rampant addiction.

  8. October 09, 2020

    Negotiation Class Wants 6th Circ. Full Review In Opioid MDL

    A proposed negotiation class intended to seek settlements in the sprawling Ohio multidistrict litigation over the national opioid crisis is urging the Sixth Circuit for a full-court review of a decision last month striking the class down, saying the split panel went against the intent of federal class rules and its own precedent.

  9. October 08, 2020

    Pandemic Can't Delay Landmark Opioid Trial, Judge Told

    The first bellwether trial in multidistrict opioid litigation must start this month because an epidemic of painkiller addiction is just as deadly as the coronavirus pandemic, and drug companies are exaggerating the virus threat, local governments told a West Virginia judge late Thursday.

  10. October 05, 2020

    Drug Distributors Fear 'Super-Spreader' Trial In Opioid MDL

    Major drug distributors on Monday asked a West Virginia federal judge to delay an imminent bellwether trial in multidistrict opioid litigation by warning of a coronavirus "super-spreader" outbreak, while in Ohio a federal judge postponed another bellwether trial in the MDL because of COVID-19 concerns.